首页> Fertility and sterility> Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study.

Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tasuku,Harada

第一单位： Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan. Electronic address: tasuku@med.tottori-u.ac.jp.

作者： Tasuku,Harada ^[1] ; Takao,Kobayashi ^[2] ; Akihiro,Hirakawa ^[3] ; Toshiaki,Takayanagi ^[4] ; Masayoshi,Nogami ^[4] ; Takayuki,Mochiyama ^[4] ; Masashi,Hirayama ^[4] ; Jean-Michel,Foidart ^[5] ; Yutaka,Osuga ^[6]

作者单位： Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan. Electronic address: tasuku@med.tottori-u.ac.jp. ^[1] Department of Obstetrics and Gynecology, Hamamatsu Medical Center, Hamamatsu, Japan. ^[2] Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. ^[3] Department of Clinical Development, Fuji Pharma Co., Ltd., Tokyo, Japan. ^[4] Estetra SRL, Mithra Pharmaceuticals, Liège, Belgium; Department of Obstetrics and Gynecology, University of Liège, Liège, Belgium. ^[5] Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. ^[6]

关键词 Estetrol drospirenone endometriosis estrogen-progestin combination pain alleviation